Navigation Links
Universal Health Services, Inc. Announces Dividend
Date:1/20/2010

KING OF PRUSSIA, Pa., Jan. 20 /PRNewswire-FirstCall/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.05 per share on March 15, 2010 to shareholders of record as of March 1, 2010.

Universal Health Services, Inc. is one of the nation's largest hospital companies, operating, through its subsidiaries, acute care and behavioral health hospitals, and ambulatory centers nationwide and in Puerto Rico.

Certain statements in this release may constitute forward-looking statements and are subject to various risks and uncertainties as discussed in the Company's filing with the Securities and Exchange Commission.  The Company is not obligated to update these forward-looking statements even if the Company's assessment of these risks and uncertainties changes.

For additional information on the Company, visit our website; http://www.uhsinc.com.

SOURCE Universal Health Services, Inc.

RELATED LINKS
http://www.uhsinc.com

'/>"/>

SOURCE Universal Health Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at Londons Online Information 2009 Conference
2. Universal Health Services, Inc. Announces Stock Split and Cash Dividend Increase
3. CaseCruzer -- New GunCruzer 2N2Universal GunPod Case Makes Rifles and Handguns Travel Companions
4. Universal screening lowers risk of severe jaundice in infants
5. Vision for a Nation: Universal Access to Eyeglasses for the People of Rwanda
6. Obama - Care Parody Takes Look Inside Realities of Universal Health Care Plan
7. Universal Medical Systems of Ohio Introduces Charlie, Worlds First Portable, Battery-Operated, Multi-Slice CT Scanner for Pets
8. National Hispanic Medical Association Supports Universal Health Coverage
9. Free Choice to Petition Japanese Government for Right to Choose Private Health Insurance in Lieu of Japan's Universal Health Care
10. Universal influenza vaccination may reduce antibiotic use
11. Facial Expressions Not Universally Understood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... , ... August 29, 2015 , ... ... develops, may extend and improve the lives of patients, according to a newly ... Click here to read the full article. , The authors of the ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Brands like ... with zero standard shipping costs. , “Before, a threshold of $49.00 was required ... select brands and items qualify for free standard shipping for customers regardless of the ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops ... seconds of unique footage that users can shrink and stretch in the Final Cut ... Users can customize color, brightness, scale, speed, range, and flare attributes with intuitive controls ...
(Date:8/29/2015)... ... 29, 2015 , ... Hamstring strain have not ... tissue manipulation. Platelet rich plasma injections also have mixed results. Building core ... treatment outcomes. This localized treatment seems to address the symptoms and does offer ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... July 2008 Elsevier, a leading publisher of scientific, technical ... the official journal of the European Association of Urology ... , European Urology (also the "Platinum ... response and an international profile. To keep up with the ...
... Milwaukee-based Assurant Health, a,leading national provider of ... products, announces that Jennifer Kopps-Wagner has been,named ... immediately., Kopps-Wagner joined Assurant Health in ... company,s legal department. In her most recent ...
... LOUIS, July 16 Stereotaxis, Inc. (Nasdaq:,STXS) announced ... Heart and,Diabetes Center of North Reinland-Westphalia in Bad ... in a 10-year old boy. The team performed ... Pulmonary atresia is a congenital malformation of the ...
... New Center for Excellence Issue Brief, WASHINGTON, ... Government Excellence has issued its first issue brief ... Local Government Retiree Health,Benefit Plans: Myths and Realities. ... professor of economics and management, innovation, and,entrepreneurship in ...
... exemplify perseverance, ST. LOUIS, July 16 There,s ... their votes. They can vote online,and vote now for ... to elect,a new member of the 2008 Energizer(R) Keep ... of Fame celebrates everyday people whose,attributes and actions best ...
... 26 Grand Opening Festivities Will Include Health Education Fair,Tour ... "9 Steps to Optimum,Health", HUNTERSVILLE, N.C., July 16 ... is dedicated to successfully treating,diseases that were previously thought ... level of health, today announced that it will open,the ...
Cached Medicine News:Health News:Assurant Health Names Jennifer Kopps-Wagner Senior Vice President and General Counsel 2Health News:Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient 2Health News:Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient 3Health News:The Crisis in State and Local Government Retiree Health Benefit Plans: Myths and Realities 2Health News:Vote now for an Everyday Person with Never-Quit Spirit to join the Energizer(R) Keep Going(R) Hall of Fame 2Health News:Vote now for an Everyday Person with Never-Quit Spirit to join the Energizer(R) Keep Going(R) Hall of Fame 3Health News:Vote now for an Everyday Person with Never-Quit Spirit to join the Energizer(R) Keep Going(R) Hall of Fame 4Health News:Vote now for an Everyday Person with Never-Quit Spirit to join the Energizer(R) Keep Going(R) Hall of Fame 5Health News:North Carolina's Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center 2Health News:North Carolina's Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center 3
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... 2015 Research and ... of the "12th Annual Report and Survey ... to their offering. The 2015 12th ... and Production is the most recent study of ... projected future capacity and production. The report contains ...
(Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... issued today a shareholders, letter discussing the results of its fiscal ... Dear Imagenetix shareholder - Following ... we commence the new fiscal year, I would like to address ...   Over the past few years our primary strategy ...
... July 12, 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ... 1 clinical trial of APD811, an orally bioavailable agonist ... treatment of pulmonary arterial hypertension, or PAH. ... tolerability and pharmacokinetics of 0.03 mg, 0.05 mg, 0.1 ...
Cached Medicine Technology:Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 2Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 4
... Quality Analysis System) developed by Pablo Artal, ... first diagnostic tool for ophthalmology that provides ... system. Never before has an ophthalmologist had ... quality of vision. , ,OQAS works by ...
... -Chagas is an in-vitro diagnostic test ... to Trypanosoma cruzi in human serum/plasma. ... particle-agglutination assay using gelatin particles coated ... coated gelatin particles are agglutinated in ...
Inquire...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
Medicine Products: